Dr. med. Markus Eckstein



Organisationseinheit


Pathologisches Institut


Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 4 Go to next page Go to last page

Sikic, D., Wirtz, R.M., Wach, S., Dyrskjot, L., Erben, P., Bolenz, C.,... Keck, B. (2019). Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts. Translational Oncology, 12(4), 661-668. https://dx.doi.org/10.1016/j.tranon.2019.01.005
Bergler, M., Benz, M., Rauber, D., Hartmann, D., Kötter, M., Eckstein, M.,... Geppert, C. (2019). Automatic Detection of Tumor Buds in Pan-Cytokeratin Stained Colorectal Cancer Sections by a Hybrid Image Analysis Approach. In Reyes-Aldasoro CC, Janowczyk A, Veta M, Bankhead P, Sirinukunwattana K (Eds.), Digital Pathology (pp. 83--90). Warwick , UK: Cham: Springer International Publishing.
Eckstein, M., Sailer, V., Nielsen, B.S., Wittenberg, T., Wiesmann, V., Lieb, V.,... Wach, S. (2019). Co-staining of microRNAs and their target proteins by miRNA in situ hybridization and immunohistofluorescence on prostate cancer tissue microarrays. Laboratory Investigation. https://dx.doi.org/10.1038/s41374-019-0251-8
Martini, T., Heinkele, J., Mayr, R., Weis, C.-A., Wezel, F., Wahby, S.,... Erben, P. (2019). Erratum to 'Predictive value of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy' [Urologic Oncology: Seminars and Original Investigations 36/12 (2018) 505-534]. Urologic Oncology-Seminars and Original Investigations, 37(3), 227-227. https://dx.doi.org/10.1016/j.urolonc.2018.12.019
Breyer, J., Wirtz, R.M., Erben, P., Rinaldetti, S., Worst, T.S., Stoehr, R.,... Otto, W. (2019). FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer. Bju International, 123(1), 187-196. https://dx.doi.org/10.1111/bju.14525
Musa, G., Cazorla-Vázquez, S., van Amerongen, M.J., Stemmler, M., Eckstein, M., Hartmann, A.,... Engel, F. (2019). Gpr126 (Adgrg6) is expressed in cell types known to be exposed to mechanical stimuli. Annals of the New York Academy of Sciences. https://dx.doi.org/10.1111/nyas.14135
Spachmann, P.J., Azzolina, V., Weber, F., Evert, M., Eckstein, M., Denzinger, S.,... Breyer, J. (2019). Loss of CHEK2 Predicts Progression in Stage pT1 Non-Muscle-Invasive Bladder Cancer (NMIBC). Pathology & Oncology Research. https://dx.doi.org/10.1007/s12253-019-00745-7
Eckstein, M., & Gupta, S. (2019). New insights in predictive determinants of the tumor immune microenvironment for immune checkpoint inhibition: a never ending story? Annals of translational medicine, 7. https://dx.doi.org/10.21037/atm.2019.06.12
Eckstein, M., Erben, P., Kriegmair, M.C., Worst, T.S., Weiss, C.-A., Wirtz, R.M.,... Erlmeier, F. (2019). Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab. European journal of cancer, 106, 234-243. https://dx.doi.org/10.1016/j.ejca.2018.11.007
Gevaert, T., Cimadamore, A., Eckstein, M., Scarpelli, M., Lopez-Beltran, A., Cheng, L., & Montironi, R. (2019). Predictive biomarkers for immunotherapy in the treatment of advanced urothelial carcinoma: Where we stand and where we go. Future Oncology, 15(19), 2199-2202. https://dx.doi.org/10.2217/fon-2019-0217

Zuletzt aktualisiert 2017-05-09 um 02:00